| Product dosage: 0.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.91 | $57.19 (0%) | 🛒 Add to cart |
| 60 | $1.81 | $114.38 $108.36 (5%) | 🛒 Add to cart |
| 90 | $1.77 | $171.57 $159.53 (7%) | 🛒 Add to cart |
| 120 | $1.76 | $228.76 $210.70 (8%) | 🛒 Add to cart |
| 180 | $1.74 | $343.15 $313.05 (9%) | 🛒 Add to cart |
| 270 | $1.72
Best per pill | $514.72 $465.55 (10%) | 🛒 Add to cart |
Similar products
More info:
Dutasteride: Effective Management for BPH and Hair Loss - Evidence-Based Review
Dutasteride, marketed under brand names like Avodart and more recently in generic forms, is a 5-alpha-reductase inhibitor primarily used in managing benign prostatic hyperplasia (BPH) and male pattern hair loss. It works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a hormone implicated in prostate growth and hair follicle miniaturization. Unlike finasteride, which blocks only type II 5-alpha-reductase, dutasteride inhibits both type I and II isoforms, leading to more profound and sustained suppression of DHT levels—up to 90% reduction compared to about 70% with finasteride.
avodart
Dutasteride, marketed as Avodart, represents one of the more interesting developments in urological pharmacotherapy over the past two decades. As a 5α-reductase inhibitor, it occupies a unique position in managing benign prostatic hyperplasia, though its applications have expanded beyond initial indications. What’s particularly fascinating isn’t just its mechanism—which we’ll explore—but the clinical nuances that emerge when you’ve prescribed it to hundreds of patients across different demographic profiles. I remember my first complex BPH case involving Avodart—a 62-year-old attorney named Robert who’d failed multiple alpha-blocker regimens due to orthostatic hypotension.
Flomax: Targeted Relief for BPH Symptoms - Evidence-Based Review
Flomax, known generically as tamsulosin hydrochloride, represents a significant advancement in the management of lower urinary tract symptoms attributed to benign prostatic hyperplasia. As an alpha-1 adrenergic receptor antagonist, it specifically targets receptors in the prostate and bladder neck, offering a more selective mechanism than previous generations of alpha-blockers. The clinical relevance of Flomax lies in its ability to improve urinary flow rates and reduce symptoms like hesitancy, weak stream, and nocturia with a favorable side effect profile compared to non-selective alpha-antagonists.
proscalpin
Proscalpin represents one of those rare clinical tools that fundamentally shifts how we manage a frustratingly common condition. It’s a Class II medical device, specifically a topical applicator system that delivers a standardized botanical extract complex through a patented transdermal hydrogel. We initially developed it for androgenetic alopecia, but its applications have broadened significantly in my practice. The core innovation isn’t the active compounds themselves—saw palmetto liposterolic extract, caffeine, and adenosine are well-documented—but the delivery system that achieves consistent follicular penetration without systemic absorption.
proscar
Proscar, known generically as finasteride, is a prescription medication classified as a 5-alpha-reductase inhibitor. It’s not a dietary supplement or medical device in the traditional sense, but rather a well-established pharmaceutical agent primarily used in managing benign prostatic hyperplasia (BPH) and, at a lower dose, for male pattern hair loss. The active ingredient, finasteride, works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a hormone implicated in prostate growth and hair follicle miniaturization.
Uroxatral: Effective Symptom Relief for Benign Prostatic Hyperplasia - Evidence-Based Review
Uroxatral, known generically as alfuzosin, is an alpha-1 adrenergic receptor antagonist specifically formulated as an extended-release tablet. It belongs to the class of drugs called alpha-blockers and is primarily indicated for the symptomatic management of benign prostatic hyperplasia (BPH). Unlike immediate-release formulations, Uroxatral’s unique delivery system provides steady plasma concentrations, which translates to more consistent relief from urinary symptoms with a potentially reduced side effect profile. This makes it a cornerstone in urological practice for managing what we commonly call “prostate enlargement” symptoms in aging male patients.
abana
Product Description Abana represents one of those formulations that initially puzzled me when I first encountered it in practice - a comprehensive herbal supplement with roots in Ayurvedic medicine, primarily indicated for cardiovascular support. What struck me during my early years at the Cleveland Clinic was how this multi-herb preparation kept appearing in patients’ medication lists, particularly among those with familial hyperlipidemia patterns. The formulation contains a sophisticated blend of Terminalia arjuna, Inula racemosa, Commiphora mukul, and several other botanicals that work synergistically - something we rarely see in single-component pharmaceuticals.
abhigra
Product Description: Abhigra represents a novel class of medical-grade nutraceutical devices that combines standardized botanical extracts with a patented sublingual delivery system. Unlike conventional supplements, its mechanism relies on transmucosal absorption bypassing first-pass metabolism, which we’ve observed yields significantly faster onset of action—particularly valuable for acute inflammatory episodes. The development team spent three years battling stability issues with the nanoemulsion matrix before discovering that alternating temperature cycles during production actually enhanced bioactive preservation, contrary to our initial assumptions.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike first-generation antipsychotics that primarily function as dopamine D2 receptor antagonists, aripiprazole exhibits a unique mechanism as a partial dopamine agonist. This pharmacological profile allows it to stabilize dopamine activity rather than simply blocking it, creating what many clinicians describe as a “dopamine stabilizer” effect. The medication has received FDA approval for multiple psychiatric conditions including schizophrenia, bipolar disorder, major depressive disorder (as adjunct treatment), Tourette’s disorder, and irritability associated with autistic disorder.